Huaijun Zhou

ORCID: 0000-0002-6994-2747 · 8 papers in corpus
case-report 2026
Frontiers in oncology ·doi:10.3389/fonc.2026.1706736

OBJECTIVE: To present two cases of primary ovarian squamous-cell carcinoma (POSCC) and describe a comprehensive review and analysis of the published related literature. METHODS: We reviewed the medical records of two patients with POSCC wh…

observational 2026
International journal of women's health ·doi:10.2147/IJWH.S536956

PURPOSE: To characterize the clinical phenotypes of congenital genital tract malformations and evaluate their associations with endometriosis (EM) and fertility outcomes. PATIENTS AND METHODS: This retrospective cohort study analyzed 306 w…

lab-animal 2025
iScience ·doi:10.1016/j.isci.2025.112422

Sheep (Ovis aries) are valuable biomedical models for studying human reproductive biology, however, the transcriptional dynamics underlying their ovarian development remain insufficiently characterized. In this study, we profiled 61,649 sin…

observational 2024
BMC women's health ·doi:10.1186/s12905-024-03227-4

BACKGROUND: Endometriosis is considered as a systemic disease with the presence of proinflammatory cytokines in the circulation, which drives hypercoagulable state of endometriosis. Currently, endometriosis is classified into four stages: I…

2024
·doi:10.21203/rs.3.rs-3884274/v1

Abstract Background Endometriosis is considered as a systemic disease with the presence of proinflammatory cytokines in the circulation, which drives hypercoagulable state. Currently, endometriosis is classified into four stages: I (minimal…

lab-animal 2020
Molecular therapy. Methods & clinical development ·doi:10.1016/j.omtm.2020.09.013

Endometriosis is a benign disease that shares some malignant features. Epithelial-mesenchymal transition (EMT) is involved in the pathogenesis of endometriosis. Metastasis-associated protein 1 (MTA1) plays an important role in various cance…

2020
·doi:10.2139/ssrn.3537066
case-report 2013
Molecular and clinical oncology ·doi:10.3892/mco.2013.144

Minimal deviation adenocarcinoma (MDA) of the uterine cervix, otherwise known as adenoma malignum, is a rare variant of cervical adenocarcinoma, which represents a diagnostic challenge in the field of gynecologic oncology, due to its benign…